Storia della carriera di Robert Eberwein
Precedenti posizioni note di Robert Eberwein
Società | Posizione | Inizio | Fine |
---|---|---|---|
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Direttore operativo | 01/01/2017 | 01/09/2017 |
Corporate Officer/Principal | 05/01/2011 | - | |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Corporate Officer/Principal | - | - |
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - | - |
CAMBREX CORPORATION | Corporate Officer/Principal | - | - |
Formazione di Robert Eberwein
Hood College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 4 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
Aziende private | 3 |
---|---|
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |
Cambrex Corp.
Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
- Borsa valori
- Insiders
- Robert Eberwein
- Esperienza